IRIS - Res&Arch Institutional Research Information System - Research & Archive

VERSO, Melina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.471
EU - Europa 1.140
AS - Asia 974
SA - Sud America 200
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 3.809
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.441
SG - Singapore 514
IE - Irlanda 237
IT - Italia 226
UA - Ucraina 189
BR - Brasile 176
RU - Federazione Russa 135
HK - Hong Kong 132
CN - Cina 130
DE - Germania 91
VN - Vietnam 85
SE - Svezia 74
FI - Finlandia 70
TR - Turchia 41
GB - Regno Unito 34
KR - Corea 21
CA - Canada 19
FR - Francia 18
AT - Austria 16
BE - Belgio 14
PL - Polonia 9
IN - India 8
NL - Olanda 8
BD - Bangladesh 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
AR - Argentina 6
CH - Svizzera 5
IQ - Iraq 5
JP - Giappone 5
MX - Messico 5
JO - Giordania 4
LB - Libano 4
VE - Venezuela 4
CO - Colombia 3
EC - Ecuador 3
EU - Europa 3
LT - Lituania 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CL - Cile 2
EG - Egitto 2
ES - Italia 2
ID - Indonesia 2
KE - Kenya 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
SV - El Salvador 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KZ - Kazakistan 1
MA - Marocco 1
PA - Panama 1
PS - Palestinian Territory 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TN - Tunisia 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.809
Salva come PNG Salva come JPEG
Città #
Singapore 321
Dublin 232
Chandler 215
San Mateo 133
Hong Kong 130
Jacksonville 111
Perugia 90
Altamura 70
Boardman 67
Santa Clara 67
Ann Arbor 66
Ashburn 61
Medford 61
Princeton 60
Lawrence 56
Moscow 46
Wilmington 46
Andover 41
Izmir 36
Munich 34
Dong Ket 27
Des Moines 26
Ho Chi Minh City 24
Los Angeles 24
Beijing 21
Seoul 21
New York 18
Saint Petersburg 17
Norwalk 15
Brussels 14
Helsinki 14
São Paulo 14
The Dalles 14
San Paolo di Civitate 13
Hanoi 11
Redmond 11
Turku 11
Brooklyn 8
Dallas 8
Rio de Janeiro 8
Rome 8
Piscataway 7
Redwood City 7
Atlanta 6
Johannesburg 6
Montreal 6
New Orleans 6
Nuremberg 6
Vienna 6
Warsaw 6
Woodbridge 6
Belo Horizonte 5
Chicago 5
Seattle 5
Shanghai 5
Stockholm 5
Toronto 5
Amman 4
Bologna 4
Boston 4
Denver 4
Falkenstein 4
Fortaleza 4
Goslar 4
Guangzhou 4
Parabiago 4
San Francisco 4
Tokyo 4
Charlotte 3
Haiphong 3
Houston 3
Kocaeli 3
London 3
Manchester 3
Piracicaba 3
Porto Alegre 3
Vancouver 3
Amsterdam 2
Auckland 2
Biên Hòa 2
Bogotá 2
Brasília 2
Bắc Giang 2
Cabo Frio 2
Campo Grande 2
Caracas 2
Curitiba 2
Delhi 2
Den Haag 2
Falls Church 2
Guarulhos 2
Hòa Bình 2
Lima 2
Miami 2
Mumbai 2
Narni 2
Ourinhos 2
Padova 2
Paris 2
Park Ridge 2
Totale 2.479
Salva come PNG Salva come JPEG
Nome #
Epidemiology of cerebral vein and sinus thrombosis. 109
Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. 98
Risk factors for venous thromboembolism in the elderly: results of the master registry. 97
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 92
Venous thromboembolism associated with long-term use of central venous catheters in cancer patients 89
Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism 89
Factors associated with the timing of diagnosis of venous thromboembolism: results from the MASTER registry. 89
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score. 88
[Heparin in anesthesia. Pharmacological and clinical aspects in the prophylaxis of venous thromboembolism]. 83
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 82
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry 80
Epidemiology of cerebral vein and sinus thrombosis 80
A prospective study on survival in cancer patients with and without venous thromboembolism. 79
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism 78
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 77
Chemotherapy-associatedthromboembolic risk in cancer outpatients and effect of nadroparinthromboprophylaxis: results of a retrospective analysis of the PROTECHT study. 76
Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter-related deep vein thrombosis in a child with acute lymphoblastic leukemia. 74
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 74
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 74
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 73
Apixaban for the treatment of venous thromboembolism associated with cancer 72
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. 71
Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients 69
Successful treatment with dermatan sulfate in six patients with heparin-induced thrombocytopenia and acute venous thromboembolism. 68
A commentary: to screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registry. 66
Do italian vascular centers look for isolated calf deep vein thrombosis? Analysis of isolated calf deep vein thromboses included in the ''Master'' Registry. 65
Incidence of Ct scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinoma 65
Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). 63
Thromboprophylaxis during chemotherapy in patients with advanced cancer. 58
New oral anticoagulants and their management in dental practice 57
Treatment of venous thromboembolism in patients with cancer: What news from clinical trials? 57
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 56
Building effective prophylaxis of deep vein thrombosis in the outpatient setting. Blood Coagul Fibrinolysis. 55
Risk factors of catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. 55
Do antiangiogenics promote clot instability? Data from the TESEO prospective registry and Caravaggio clinical trial. 55
Seasonal variation in the occurrence of venous thromboembolism: data from the MASTER Registry. 54
Long-term death and recurrence in patients with acute venous thromboembolism: The MASTER registry. 54
Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. 53
Unmet clinical needs in the prevention and treatment of cancer-associated venous thromboembolism 53
Prevention of venous thromboembolism in patients with advanced lung cancer receiving chemotherapy: a combined analysis of the protecht and topic-2 studies. 52
Thromboprophylaxis during chemotherapy after advanced cancer. 52
Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort 52
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. 51
Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study 51
Management of venous thromboembolism in patients with cancer. 50
PL-21 New and old anticoagulants in cancer. 50
Thrombosis and cancer: clinical relevance of a dangerous liaison. 48
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 48
Third national surgical consensus conference of the Italian Association of Breast Surgeons (ANISC) on management after neoadjuvant chemotherapy: The difficulty in reaching a consensus 46
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. 46
Therapy insight:venous-catheter-related thrombosis in cancer patients 46
Treatment of venous thromboembolism in patients with cancer: from clinical trials to real life 46
Prophylaxis of upper limb deep vein thrombosis in cancer patients with central vein catheter 44
Pros and cons of new oral anticoagulants in the treatment of venous thromboembolism in patients with cancer 43
Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding 41
To the editor: The effect of low-molecular-weight heparin in cancer patients: The mirror image of survival? 40
New strategies of VTE prevention in cancer patients. 39
The MASTER registry on venous thromboembolism: description of the study cohort. 39
Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master Registry 38
Prophylaxis against venous thromboembolism in patients with cancer [3] 38
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer 38
Targeted anti-cancer agents and risk of venous thromboembolism 33
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 31
Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidence 29
Totale 3.918
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.226
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021198 0 0 0 0 0 13 38 11 42 29 34 31
2021/2022505 8 86 8 13 24 4 5 161 6 45 70 75
2022/2023798 67 189 15 44 49 89 0 28 283 1 27 6
2023/2024228 18 25 24 3 3 0 39 9 7 14 50 36
2024/2025827 0 68 1 39 126 39 52 41 153 60 175 73
2025/2026745 128 102 95 159 224 37 0 0 0 0 0 0
Totale 3.918